Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kerendia
Pharma
FDA broadens label for Bayer's Kerendia to treat heart failure
The FDA has expanded the label of Bayer’s kidney disease drug Kerendia to include treatment of patients with two types of heart failure.
Kevin Dunleavy
Jul 14, 2025 8:39am
FDA approves use of Bayer's Nubeqa in all patients with mCSPC
Jun 4, 2025 11:38am
Bayer weathers LOE for Xarelto with success of Kerendia, Nubeqa
May 13, 2025 11:25am
Bayer projects Xarelto's sales decline will gain steam in 2025
Mar 5, 2025 11:17am
JPM25: Bayer gears up for 'must-win battles' amid Xarelto decline
Jan 15, 2025 8:00pm
Wegovy and Zepbound tipped to fuel $20B heart failure boom
Jan 7, 2025 11:12am
